Publication
Article
BioPharm International
BioPharm International-10-01-2002Volume15 Issue 10
Biotech Will Recover!
Author(s):
by G. Steven Burrill, Burrill & Company Beleagured by bad news since the start of the year, biotech is barely registering a pulse on Wall Street . . . but it's hardly time to write the industry's obituary.
Articles in this issue
FDA Launches Major CGMP Review
Virus Inactivation in the 1990s ? and into the 21st Century: Part 3b, Plasma and Plasma Products (Treatments Other than Heat or Solvent/Detergent)
Process Validation: How Much to Do and When to Do It
Biotech Will Recover!
Preparing Biological Product Deviation Reports: Suggestions for Manufacturers
GMPs and Pharmaceutical Labeling
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
